When first line therapy for AA-amyloidosis secondary to rheumatoid arthritis fails: A correspondence

Saved in:
Bibliographic Details
Published inJoint, bone, spine : revue du rhumatisme Vol. 80; no. 2; pp. 229 - 230
Main Authors Burkart, Jarred, Benson Jr., Don Michael
Format Journal Article
LanguageEnglish
Published France Elsevier SAS 01.03.2013
Subjects
AA amyloidosis
Amyloidosis - blood
Amyloidosis - drug therapy
Amyloidosis - etiology
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - complications
Arthritis, Rheumatoid - drug therapy
Female
Humans
Internal Medicine
Middle Aged
Rheumatoid arthritis
Rheumatology
Rituximab
Serum Amyloid A Protein - metabolism
Treatment Failure
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor necrosis factor-α
Rituximab
AA amyloidosis
Tumor necrosis factor-α
Rheumatoid arthritis
Online AccessGet full text

Cover

More Information
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2012.08.008